Aim: Serum cholesterol efflux has been suggested to be a key anti-atherogenic function of reverse cholesterol transport. Meanwhile, the quantitative and qualitative alteration of the levels of lipoproteins in the serum has been reported in patients with diabetes, although it remains unclear whether the serum cholesterol efflux capacity is impaired in cases of newly diagnosed glucose intolerance. We thus assessed the relationship between the serum cholesterol efflux capacity and glucose intolerance as detected using oral glucose tolerance tests (OGTTs). Methods: We measured the capacity of whole serum to mediate cholesterol efflux from human THP-1 macrophages in a cohort of 439 Japanese-Americans who underwent 75-g OGTTs. A multiple regression analysis was performed to examine the relationship between the serum cholesterol efflux capacity and glucose intolerance. Results: The serum cholesterol efflux capacity was found to be negatively correlated with the area under the curve for the serum glucose concentration during the 75-g OGTTs in all subjects. In addition, the serum cholesterol efflux capacity was found to be modestly but significantly lower in the glucose intolerance group (31.4±6.2%) than in the normal glucose tolerance group (33.2±6.1%). There was also a negative association between the serum cholesterol efflux capacity and glucose intolerance after adjusting for age and sex. Moreover, this association remained significant even after further adjustments for serum total cholesterol, high-density lipoprotein cholesterol, apolipoprotein AI and C-reactive protein.
Introduction
In patients with diabetes, atherosclerotic disease is an important determinant of the life expectancy, developing two to three times more often than that observed in patients without diabetes 1) and accountingfor30-40%ofmortalityinthispopulation 2) .The riskofatheroscleroticdiseasemayincreaseevenatthe stage of impaired glucose tolerance (IGT), which is generallyconsideredtobeapre-diabeticstate [3] [4] .One of the causes of the high frequency of atherosclerosis in patients with glucose intolerance is the accumulation in serum of atherogenic lipoproteins, such as remnant lipoproteins, small dense low-density lipoproteins (LDL) and oxidized LDL [5] [6] . Namely, patientswithglucoseintolerancedisplayatypicalpattern of atherogenic dyslipidemia. In contrast, the cally equivalent to Japanese residing in Japan, although they have experienced rapid and intense westernization of their lifestyle. We previously reported that the prevalence of diabetes, metabolic syndrome and atherosclerotic disease is significantly greaterinJapanese-AmericansthaninJapaneseliving in Japan [17] [18] [19] .The effects of glucose and lipid abnormalities on the serum cholesterol efflux capacity are thereforeexpectedtobemorereadilyapparentinthis populationthaninnativeJapanese.
Materials and Methods

Study Subjects
The present study is part of a long-term epidemiological survey (Hawaii-Los Angeles-Hiroshima study) initiated in 1970 that continues to investigate risk factors for diabetes and cardiovascular disease among subjects limited to a population genetically equivalenttothenativeJapanesepopulation.Theepidemiological survey has been previously described in detailelsewhere [17] [18] [19] [20] .Thesubjectsofthepresentstudy were Japanese-Americans enrolled in the Los Angeles portionofthelong-termepidemiologicalstudycarried out in 2010.The study population consisted of 439 Japanese-Americans(186menand253women)who werenotdiagnosedwithDMandnotusingmedications for dyslipidemia. We also excluded individuals withafastingtriglyceride(TG)levelofmorethan400 mg/dl in consideration of the use of the Friedewald equation 21) . The glucose tolerance status was ascertainedineachsubjectandclassifiedasfollows:normal glucose tolerance (NGT), IGT or DM according to theresultsofthe75-gOGTT.ThediagnosisofDM was made in accordance with the American Diabetes Association 1997 glucose-tolerance standards 22) , as follows:afastingserumglucose(FSG)levelof≥ 126 mg/dlortwo-hourserumglucose(2-hSG)levelof≥ 200 mg/dl after oral glucose loading. The smoking status(never,pastorcurrent)wasassessedusingstandard interview procedures. All subjects received an explanationoftheproceduresandprovidedtheirwritteninformedconsent.Thisstudywasapprovedbythe Ethics Committee of Hiroshima University, and the Council of Hiroshima Kenjin-Kai Association in Los Angeles.
Biochemical Analyses
All subjects underwent physical measurements and provided blood and urine samples after an overnight fast. The collected blood samples were centrifuged,andtheobtainedserumsampleswereimmediatelyfrozenandtransportedtoJapan.Theserumgluplasmaconcentrationofanti-atherogenichigh-density lipoproteincholesterol(HDL-C)tendstodecreasein thepresenceofglucoseintolerance 5) .Glucoseintolerance, moreover, promotes the glycation of HDL itself 5) .Takentogether,inpatientswithglucoseintolerance,bothquantitativeandqualitativealterationof the levels of lipoproteins is hypothesized to decrease theanti-atherogeniceffectsintheserum.
Themostwidelyacceptedanti-atherogenicproperty in organisms is the centripetal return of excess cholesterolfrommacrophagefoamcellsinperipheral arteriestotheliverforexcretionintothebileandultimately the feces via the reverse cholesterol transport (RCT)pathway 7) .Cholesteroleffluxistheinitialstep of the RCT and represents the ability of serum-containingHDLparticlestopromotetheRCTbyacceptingcholesterolfromlipid-ladenmacrophages 8) .Consequently, measuring the serum cholesterol efflux capacityisexpectedtohaveclinicalutilityinthefunctionalassessmentofRCT.Infact,recentstudieshave demonstratedarobustassociationbetweentheserum cholesterol efflux capacity and cardiovascular outcomes,independentoftheserumHDL-Cconcentration 9) ,andthatstatintreatmentresultsinanimproved cholesterol efflux capacity 10) . Moreover, the use of wholeserumasacholesterolacceptorforeffluxassay has been hypothesized to be a physiological method for ex vivo study, as the capacity of whole serum to induce cholesterol efflux from cells provides comprehensive and accurate data regarding lipoproteins and serum components, such as cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT) and phospholipid transfer protein (PLTP), involved in modifying HDL and promoting cellular cholesterolefflux [11] [12] [13] . Accordingtoseveralreportsthathaveexamined cholesterol efflux to the serum or plasma in subjects with type 2 diabetes mellitus (DM) [14] [15] [16] , serum cholesterol efflux is thought to be influenced by various effectsofglucoseintolerance.However,tothebestof ourknowledge,noreportshaveyetassessedtheserum cholesteroleffluxcapacityinpatientswithnewlydiagnosedglucoseintolerance,asdetectedusing75-goral glucosetolerancetests(OGTTs).
Wethereforehypothesizedthatserumcholesterol efflux as a key anti-atherogenic function of the RCT may be impaired in subjects with newly diagnosed glucose intolerance, leading to a residual risk of atherosclerosis.Inordertoinvestigatethishypothesis,we assessed the relationship between the serum cholesterol efflux capacity and glucose intolerance in Japanese-Americans who underwent 75-g OGTTs. Japanese-AmericanslivingintheUnitedStatesaregeneti-thesumoftheradioactivityinthemediaandcells 28) . Theabilityofindividualserumtopromotecholesterol efflux was calculated by subtracting values obtained withoutserum in order toexclude theeffectsof passivediffusion.Tominimizeintra-assayvariability,each serum sample was run in triplicate, and the average andstandarddeviationvalueswerecalculatedforeach percent of efflux obtained. To correct for inter-assay variability,apoolofhumanserumwastestedineach assay as a reference standard, and its efflux capacity was used to normalize the subject sample values obtained from different experiments. The calculated mean intra-and inter-assay coefficients of variation were6.64%and7.76%,respectively.
Measurement of Atherosclerotic Lesions
The carotid artery intima-media wall thickness (IMT) was measured using B-mode ultrasonography (EUB-405X; Hitachi,Tokyo, Japan) with a 10-MHz probe according to a technique developed by Pignoli et al. 29) . The IMT measurement protocol has been previously described 19) . All measurements were obtainedbyonephysicianusingthesameequipment.
Statistical Analysis
The data are expressed as the mean value and standard deviation or median (25th-75th percentile), dependingonthedatadistribution.Forvariableswith a skewed distribution, log-transformation was performedpriortotheanalysis.Thistransformationwas applied to the body mass index (BMI), fasting IRI (FIRI), two-hour IRI after oral glucose loading (2-h IRI),totalareaunderthecurve(AUC)forIRIduring OGTT (OGTTAUC IRI), incremental AUC for IRI during OGTT (OGTTIAUC IRI), HOMA-IR, TG, CRPandIMTvalues.First,basedontheresultsofthe 75-gOGTT,theserumcholesteroleffluxcapacitywas examinedinthreesubgroupsdefinedaccordingtothe glucose tolerance status: NGT, IGT and DM. Next, in order to examine the influence of the presence of glucose intolerance on the serum cholesterol efflux capacity,wecombinedtheIGTandDMgroupsinto asingleglucoseintolerancegroup.Wethenexamined the serum cholesterol efflux capacity in the NGT groupandthesingleglucoseintolerancegroup.Continuous variables were compared using an age-and sex-adjusted analysis of covariance (ANCOVA) for comparisondependingonthecategoryoftheglucosetolerance status. Categorized variables were analyzed accordingtoaχ 2 analysis.ThetotalAUCforserum glucose during the OGTT (OGTTAUC glucose) and OGTTAUC IRI values were determined according to the trapezoidal method based on the FSG, 1-h SG, cose levels were measured according to the glucose oxidase method. Immunoreactive insulin (IRI) was measuredusingadouble-antibodyradioimmunoassay (Yamasa, Tokyo, Japan), and the degree of insulin resistance was evaluated with the homeostasis model assessmentforinsulinresistance(HOMA-IR)value 23) . The hemoglobin A1c (HbA1c) values were assessed accordingtothehigh-performanceliquidchromatography method using the HLC-723G7 Automated Glycohemoglobin Analyzer (Tosoh, Tokyo, Japan). The obtained HbA1c values were converted to National Glycohemoglobin Standardization Program (NGSP)-equivalent values using the official equation 24) .TheC-reactiveprotein(CRP)levelsweremeasured using a highly sensitive, latex-enhanced immunonephelometricassay(DenkaSeiken,Tokyo,Japan). The serum total cholesterol (T-Cho) and TG levels were assessed according to an enzymatic method (Kyowa Medex, Tokyo, Japan). The HDL-C levels were measured directly using a homogenous assay (KyowaMedex,Tokyo,Japan),andtheLDL-Clevels werecalculatedusingtheFriedewaldequation 21) .The apolipoprotein AI (apo-AI) and apolipoprotein B (apo-B)levelsweremeasuredusinganimmuno-nephelometryassay(SekisuiMedical,Tokyo,Japan).
Cholesterol Efflux Assay
The cholesterol efflux assay has been previously described 25) . Briefly, THP-1 cells (Riken Cell Bank, Tsukuba, Japan) were maintained in RPMI 1640 (NikkenBio,Kyoto,Japan)containing10%fetalbovine serum. THP-1 cells were differentiated into macrophages with 320 nmol/l phorbol 12-myristate13-acetatefor72hours.Forthemeasurementofcholesterol efflux, the cells were cultured in a 24-well plate at a densityof1.0×10 6 cells/well.Themacrophageswere washed twice with phosphate buffered saline (PBS) and labeled via incubation in the presence of [ 3 H]-cholesterol(PerkinElmer,Boston,USA;finalconcentration 0.33 μCi/ml) in medium containing 0.2% bovine serum albumin (BSA) for 24 hours.The cells were washed twice with PBS containing 0.2% BSA andincubatedfor24hoursat37 ℃ inmediumcontaining0.2%BSAinthepresenceof0.5%serum(v/v) obtained from the study subjects as a cholesterol acceptor [25] [26] [27] .Followingincubation,thecultureswere centrifuged to remove cell debris, and the medium wasremovedtodeterminethelevelofradioactivity.At theendofthechaseperiod,themacrophagesweredissolved in a 3:2 (v/v) mixture of hexane/isopropanol, and the level of radioactivity per aliquot was measured.Thepercentageofcholesteroleffluxwascalculated by dividing the media-derived radioactivity by serum cholesterol efflux capacity was 32.6±5.7% in themenintheNGTgroup,31.6±6.0%inthemen intheIGTgroupand31.3±7.2%inthemeninthe DM group, compared to 33.6±6.4% in the women intheNGTgroup,31.0±6.4%inthewomeninthe IGTgroupand32.0±5.2%inthewomenintheDM group. In both sexes, the serum cholesterol efflux capacitytendedtobelowerinthesubjectswithIGT orDMthaninthosewithNGT,althoughthedifferencewasnotsignificant(P = 0.224formen,P = 0.062 forwomen).Inordertoexaminetheinfluenceofthe presenceofglucoseintolerance,wedividedthestudy subjects into an NGT group and glucose intolerance group. Consequently, the serum cholesterol efflux capacity was 33.2±6.1% in the NGT group and 31.4±6.2% in the glucose intolerance group. A significantlylowcholesteroleffluxcapacitywasobserved in the glucose intolerance group compared with that notedintheNGTgroup(P= 0.012) (Fig. 1) .Inaddition, there were significant negative correlations betweentheserumcholesteroleffluxcapacityandthe OGTTAUC glucose (r = −0.141, P = 0.025), OGT-TIAUC glucose (r = −0.185, P＜0.001) and 2-h SG (r = −0.118,P = 0.013)values( Fig. 2A-C) .
The associations between the serum cholesterol effluxcapacityandthemetabolicparametersassessed usingasingleregressionanalysisandamultipleregression analysis adjusting for age and sex are shown in Table 2 . In the single regression analysis, we found significantpositiveassociationsinallsubjectsbetween theserumcholesteroleffluxcapacityandthelevelsof T-Cho, HDL-C and apo-AI. Meanwhile, negative associationswerefoundbetweentheserumcholesterol effluxcapacityandtheBMI,CRP,2-hSGandOGT-TIAUC glucose values and glucose intolerance. After adjustingforageandsex,wefoundsignificantpositive associations between the serum cholesterol efflux capacity and the T-Cho, HDL-C and apo-AI levels. The serum cholesterol efflux capacity was also negatively associated with the CRP and OGTTIAUC glucosevaluesandglucoseintolerance.However,nosignificant relationships were observed between the serumcholesteroleffluxcapacityandthesmokingstatus, IRI level or IMT values in the single regression analysisormultipleregressionanalysisafteradjusting forageandsex.
Finally, in order to clarify the relationship betweencholesteroleffluxandglucoseintolerance,we addedthepotentialconfoundersexhibitingsignificant relationshipswiththeserumcholesteroleffluxcapacity, as shown in Table 2 , and glucose intolerance to themultipleregressionmodelsafteradjustingforage andsex (Table 3) .Amongthelipidparameters,after 2-h SG, FIRI, 1-h IRI and 2-h IRI measurements. The incremental AUC for serum glucose during the OGTT(OGTTIAUCglucose)andOGTTIAUCIRIvalues were calculated using the method recommended byWolever 30) .ThecorrelationbetweentheAUCvaluesandtheserumcholesteroleffluxcapacitywasevaluatedusingaSpearman'srankcorrelationanalysis.We also performed a regression analysis, before and after adjusting for age and sex, to assess the relationships betweentheserumcholesteroleffluxcapacityandthe metabolicparameters.Ineachregressionmodel,either theglucose-tolerancestatus(NGT = 0,glucoseintolerance = 1) or smoking status (never = 0, past = 1, current = 2)wasenteredasacategoricalvariable.P-values oflessthan0.05wereconsideredtobestatisticallysig-nificant.WeusedtheSPSSversion19softwarepack-age(IBMCorp.,Armonk,NY)forthestatisticalanalysis.
Results
Theclinicalcharacteristicsofthestudysubjects, separated into three groups according to the glucose tolerancestatusasdefinedbythe75-gOGTTresults, are indicated in Table 1 . The NGT, IGT and DM groups comprised 330, 71 and 38 subjects, respectively.Nosignificantdifferenceswereobservedregardingthesmokingstatus(never,pastorcurrent).However, the subjects in the IGT and DM groups were significantly older than those in the NGT group. In addition,theincidenceofIGTandDMtendedtobe higherinmenthaninwomen,althoughthedifference wasnotsignificant.Wethereforeanalyzedthefollowing metabolic parameters after adjusting for age and sex.TheBMI,systolicbloodpressure(SBP),FSG,2-h SG,OGTTAUCglucose,OGTTIAUCglucose,FIRI,2-h IRI, OGTTAUC IRI, OGTTIAUC IRI, HOMA-IR, HbA1c,TG,CRPandIMTvaluesweresignificantly higherintheIGTandDMgroupsthanintheNGT group.TheApo-Bvalueswerealsosignificantlyhigher in the IGT group than in the NGT group. In contrast, the HDL-C values were, as expected, significantlylowerintheIGTandDMgroups.Theserum cholesteroleffluxcapacitywas33.2±6.1%intheNGT group,31.3±6.2%intheIGTgroupand31.6±6.2% intheDMgroup.Theserumcholesteroleffluxcapacity tended to be lower in the subjects with IGT or DMthaninthosewithNGT,althoughthedifference wasnotsignificant(P= 0.061).Wesubsequentlyanalyzed the efflux capacity in men and women separately. There were no significant differences in the serum cholesterol efflux capacity between men and women(31.9±5.3％vs.32.8±5.8%;P = 0.157).The and glucose intolerance, even after additional adjustmentfortheT-Cho(model1:β= −0.128,P = 0.010), HDL-C (model 2: β= −0.113, P = 0.024), apo-AI (model 3: β= −0.116, P = 0.021), T-Cho and CRP (model4:β= −0.103,P = 0.041)levels.
Discussion
Inthisstudy,amongsubjectswithglucoseintolfurther adjusting for glucose intolerance, the serum cholesterol efflux capacity was found to be positively associated with theT-Cho levels only (model 1:β= 0.130, P = 0.010 and model 4:β= 0.137, P = 0.006). In addition, a significant negative association was observedbetweentheserumcholesteroleffluxcapacity andtheCRPlevels(model4:β= −0.115,P = 0.023). Importantly, a significant negative association was detectedbetweentheserumcholesteroleffluxcapacity ingtheABCG1expressionin vitro 40) .However,inthe presentstudyofhumans,serumcholesteroleffluxmay havebeenmorestronglyaffectedbyalterationofthe serum composition related to insulin resistance, such astheproductionofdegeneratedlipoproteins,thanby theinsulinlevelitself.
In this study, among all lipid parameters tested, the T-Cho level was observed to have the strongest positive association with the serum cholesterol efflux capacity. This observation is consistent with other recentfindingsindicatingthatdeterminantsofserum cholesteroleffluxincludeHDLandapo-AI,whichact directly as acceptors of cholesterol, and that efflux depends on the ability of HDL to pass cholesterol acquiredfromcellstocholesterolpoolswithinapo-Bcontaining lipoproteins, such asVLDL and LDL via CETP [41] [42] [43] [44] .Ontheotherhand, in thepresentstudy, HDL-Candapo-AIwereeachobservedtohaveasignificantpositiveassociationwiththeserumcholesterol efflux capacity based on the results of a multiple regressionanalysisadjustedforageandsex,butnota multiple regression analysis further adjusted for glucose intolerance. These results suggest a strong relationship between glucose intolerance and both HDL-Candapo-AIduetothemodificationofHDL byhyperglycemia 39) ,astatethatdiminishedthedirect relationships observed between serum cholesterol efflux and both HDL-C and apo-AI after adjusting glucoseintolerance.
In the present study, we found no significant associations between the IMT and cholesterol efflux values.Thisresultisinconsistentwiththefindingsof apreviousreportthatindicatedaninverserelationship between apo-B depleted serum-mediated cholesterol efflux from J774 cells and the IMT 9) . This discrepancy may be due to the fact that the efflux capacity may have not decreased to the point of influencing IMTthickening,assubjectswithNGTornewlydiagnosedglucoseintolerancewereenrolledinourstudy. Moreover,toourknowledge,nopreviousreportshave examined the relationship between IMT and cholesteroleffluxusingwholeserumorplasmaasacholesterolacceptor.Therefore,thediscrepancybetweenour results and those of the previous literature may also arise from the setting of efflux experiments, namely, thedifferencesincholesterolacceptorsandspeciesof celllinesusedascholesteroldonors.
Inthisstudy,weevaluatedthecholesterolefflux capacity using whole serum as a cholesterol acceptor foraphysiologicalassessmentinthehumanbody,as theabilityofserumtoremovecholesterolfrommacrophagesdependsonmultiplefactors,suchaslipoproteins and enzymes. In this context, the composition erance, we identified the serum cholesterol efflux capacity,ananti-atherogenicfunctionoftheRCT,as being modestly but significantly impaired. In addition, glucose intolerance was found to be independently and negatively associated with the cholesterol efflux capacity.To the best of our knowledge, this is the first report to identify a reduction in the serum cholesteroleffluxcapacityinpatientswithnewlydiagnosedglucoseintolerancedetectedon75-gOGTTs.
Possible mechanisms of the reduction in serum cholesterol efflux capacity observed in patients with glucoseintoleranceincludethefollowing.First,inthe IGTorDMgroups,insulinresistancemayreducethe numberofHDLparticlesintheserumabletoactas directandefficientcholesterolacceptors 5) .Inpatients with insulin resistance, the lipoprotein lipase activity isreduced 31) ,thusprolongingtherateofdegradation of TG components in very-low-density lipoprotein (VLDL) produced by the liver 32) . As a result, the CETPactivityisincreased,whichleadstotheproductionofTG-richHDLparticlesandareductioninthe HDL-C level 5) . TG-rich HDL readily hydrolyzes 33) , resultinginareducednumberofHDLparticles 34) .A reduction in the number of HDL particles has been reported to be associated with a diminished cholesterol efflux capacity in a healthy volunteer cohort 9) . Second, in patients with glucose intolerance, the abnormal secretion of adipokines, such as tumor necrosis factor-alpha (TNF-α) and leptin, induces chronic inflammation 35) . As a result, the level of the inflammatorymarkerCRPiselevated.CRPhasbeen reported to inhibit cholesterol efflux from THP-1 macrophagesin vitroviatheactivationofextracellular signal-regulated kinase (ERK) 1/2 and downregulation of the ATP-binding cassette transporter A1 and G1 (ABCA1/G1) expression in a dose-dependent manner 36) . Third, glucose intolerance also promotes the expression of advanced glycation end-products (AGEs) 37) ,whichcanleadtothedegradationofHDL into a dysfunctional state 38) , thus resulting in a decrease in the ability of HDL in the serum to promotecholesterolefflux 27, 39) . In addition to the finding of a reduced cholesterol efflux capacity in patients with glucose intolerance, the AUC values for the serum glucose concentration observed during the 75-g OGTTs were negatively correlated with the serum cholesterol efflux capacity.Theseresultsindicatethepresenceofadverse effectsofglucoseintoleranceoncholesterolefflux.On theotherhand,theinsulinlevelwasnotobservedto correlatedirectlywiththeeffluxcapacityinthisstudy. Insulinhasbeenreportedtosuppresscholesterolefflux frommacrophagesatpharmacologicdosesbyinhibit-no involvement in the study design, the collection, analysis or interpretation of the data, the writing of this report or the decision to submit this article for publication.
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In conclusion, we identified a reduced serum cholesterol efflux capacity in patients with glucose intolerance, as detected using 75-g OGTTs, in Japanese-Americans. Clinical physicians may therefore needtoconsidernotonlyconventionallipidparameters,butalsotheanti-atherogenicfunction,including the efflux capacity, in the whole serum in patients with glucose intolerance as a complementary assessmentoftheatheroscleroticdiseaserisk.
